Global Cardiac Assist Devices Market Size By Type (Ventricular Assist Device (VAD), Intra-aortic Balloon Pump), By Application (Hospitals, Ambulatory Surgical Centres), By Region, And Segment Forecast...

The Global Cardiac Assist Devices Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 6.3 billion by 2031, growing at a CAGR of 12.9% during the forecast period from 2023 to 2031. The market’s robust growth is driven by the rising incidence of cardiovascular diseases, advancements in cardiac assist technologies, and increasing demand for long-term circulatory support devices. With the growing aging population and prevalence of heart failure worldwide, cardiac assist devices (CADs) are becoming increasingly essential for improving patient outcomes, reducing hospitalization, and enhancing quality of life.

Drivers

1. Rising Incidence of Cardiovascular Diseases:

Heart failure, ischemic heart disease, and other cardiac disorders are on the rise due to lifestyle factors, obesity, and an aging population. Cardiac assist devices are increasingly used as a bridge-to-transplant, bridge-to-recovery, or destination therapy, driving overall market demand.

2. Technological Advancements:

The development of miniaturized, wearable, and more durable cardiac assist devices—such as implantable LVADs (Left Ventricular Assist Devices)—has improved ease of use and patient compliance, fueling market expansion.

3. Increasing Healthcare Expenditure:

Governments and healthcare organizations are investing heavily in cardiovascular care infrastructure, especially in emerging economies, enhancing accessibility to life-saving technologies like CADs.

Restraints

1. High Cost of Devices and Procedures:

The initial cost of cardiac assist devices and the surgical implantation process is considerably high, limiting their accessibility in low-income regions and among economically constrained patient populations.

2. Risk of Device-Related Complications:

Although CADs improve survival, risks such as infections, bleeding, and thrombosis remain challenges, potentially impeding their widespread adoption.

Opportunity

1. Emerging Markets and Home-Based Cardiac Care:

With rising awareness and healthcare reforms, regions like Asia-Pacific and Latin America offer lucrative opportunities. Moreover, advancements in portable and remote-monitoring CADs open doors for at-home cardiac management.

2. Strategic Collaborations and R&D:

Collaborations between medical device manufacturers, research institutions, and healthcare providers are fostering innovation and accelerating market penetration with next-generation cardiac assist solutions.

Market by System Type Insights

Based on system type, the Left Ventricular Assist Devices (LVADs) segment dominated the market in 2023, holding the largest revenue share. LVADs are the most commonly used devices for heart failure management due to their long-term support capabilities and continuous-flow technology. The Total Artificial Heart (TAH) segment is projected to witness the fastest growth, supported by technological advancements and expanding indications beyond terminal heart failure.

Market by End-use Insights

In terms of end-use, Hospitals accounted for the largest market share in 2023, driven by the high volume of cardiac surgeries and availability of specialized cardiac care units. However, Ambulatory Surgical Centers (ASCs) and Home Healthcare Settings are expected to grow rapidly due to minimally invasive procedure trends and patient preferences for at-home recovery.

Market by Regional Insights

Geographically, North America dominated the global cardiac assist devices market in 2023, attributed to its advanced healthcare infrastructure, favorable reimbursement policies, and high awareness levels. Meanwhile, Asia-Pacific is poised to grow at the highest CAGR, driven by an increasing geriatric population, government initiatives, and improving access to cardiovascular care in countries like China and India.

Competitive Scenario

Key players in the Global Cardiac Assist Devices Market include:

Abbott Laboratories

Medtronic plc

Abiomed, Inc.

Berlin Heart GmbH

ReliantHeart Inc.

Jarvik Heart Inc.

SynCardia Systems LLC

These companies are focusing on product innovation, strategic acquisitions, and regional expansion to gain a competitive edge. For instance:

In 2023, Abbott launched its new HeartMate 4 LVAD, which includes real-time monitoring features and wireless data transmission.

In 2024, Abiomed announced a strategic partnership with a leading AI firm to develop predictive analytics for cardiac recovery in CAD users.

Scope of Work – Global Cardiac Assist Devices Market

Report Metric Details

Market Size (2023) USD 2.4 Billion

Projected Market Size (2031) USD 6.3 Billion

CAGR (2023–2031) 12.9%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising cardiovascular disease burden, technological advancements, aging population

Opportunities Emerging markets, home-based cardiac care, R&D collaborations

Key Market Developments

July 2023: Medtronic received FDA approval for its latest minimally invasive cardiac assist device targeting moderate-to-severe heart failure patients.

March 2024: Berlin Heart expanded its product line with a pediatric-specific TAH, addressing unmet needs in pediatric heart failure care.

February 2025: Abbott unveiled a remote patient monitoring dashboard integrated with its latest LVAD systems, enhancing patient safety and reducing hospital visits.

FAQs

1) What is the current market size of the Global Cardiac Assist Devices Market?

The market was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Cardiac Assist Devices Market?

The major growth driver is the rising prevalence of cardiovascular diseases and heart failure worldwide.

3) Which is the largest region during the forecast period in the Global Cardiac Assist Devices Market?

North America is the largest region due to advanced healthcare systems and high adoption of cardiac technologies.

4) Which segment accounted for the largest market share in Global Cardiac Assist Devices Market?

The Left Ventricular Assist Devices (LVADs) segment held the largest share in 2023.

5) Who are the key market players in the Global Cardiac Assist Devices Market?

Key players include Abbott Laboratories, Medtronic plc, Abiomed Inc., Berlin Heart GmbH, and SynCardia Systems LLC.